Power of Prevention: The Pharmacist’s Role in Prediabetes Management

Hudspeth, Brooke

doi:10.2337/ds18-0021

Cited by 9 publications

(5 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Individuals with prediabetes can benefit from referral to an RDN for individualized medical nutrition therapy upon diagnosis and at regular intervals throughout their treatment plan (47,49). Other health care professionals, such as pharmacists and diabetes care and education specialists, may be considered for diabetes prevention efforts (50,51).…”

Section: Delivery and Dissemination Of Lifestyle Behavior Change For ...mentioning

confidence: 99%

3. Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes—2023

ElSayed¹,

Aroda²,

Bannuru³

et al. 2022

Diabetes Care

View full text Add to dashboard Cite

The American Diabetes Association (ADA) “Standards of Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA’s clinical practice recommendations and a full list of Professional Practice Committee members, please refer to Introduction and Methodology. Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.

show abstract

Section: Delivery and Dissemination Of Lifestyle Behavior Change For ...mentioning

confidence: 99%

3. Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes—2023

ElSayed¹,

Aroda²,

Bannuru³

et al. 2022

Diabetes Care

View full text Add to dashboard Cite

show abstract

“…The importance of grant funding to pharmacy is not specific to diabetes prevention programs but instead to myriad services such as hepatitis C point-of-care testing and prenatal breastfeeding services (9,10). Previous research explored development of business models for care services delivery in pharmacies (11).…”

Section: Discussionmentioning

confidence: 99%

Community Pharmacy Engagement in Diabetes Prevention: Key Informant Interviews with Pharmacy Executives

Roszak

Ferreri

2020

Prev. Chronic Dis.

View full text Add to dashboard Cite

What is already known on this topic? Effective yet underused strategies exist to prevent or delay the onset of type 2 diabetes. Community pharmacies are accessible destinations for preventive and chronic care management, and some pharmacies offer diabetes prevention services, including diabetes testing and lifestyle-change interventions. What is added by this report? This study identified factors that influence whether community pharmacies adopt and implement diabetes testing and National Diabetes Prevention Program (DPP) lifestyle-change interventions. What are the implications for public health practice? Community pharmacies can offer diabetes testing and the National DPP lifestyle-change intervention, both of which support public health goals to increase awareness and action for people with prediabetes. Barriers to implementation of diabetes prevention programs should be addressed.

show abstract

“…Individuals with prediabetes can benefit from referral to an RDN for individualized medical nutrition therapy upon diagnosis and at regular intervals throughout their treatment regimen (48,49). Other allied health professionals, such as pharmacists and diabetes care and education specialists, may be considered for diabetes prevention efforts (50,51).…”

Section: Delivery and Dissemination Of Lifestyle Behavior Change For Diabetes Preventionmentioning

confidence: 99%

3. Prevention or Delay of Type 2 Diabetes and Associated Comorbidities: Standards of Medical Care in Diabetes—2022

2021

Diabetes Care

View full text Add to dashboard Cite

The American Diabetes Association (ADA) “Standards of Medical Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee (https://doi.org/10.2337/dc22-SPPC), are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA’s clinical practice recommendations, please refer to the Standards of Care Introduction (https://doi.org/10.2337/dc22-SINT). Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.

show abstract

Power of Prevention: The Pharmacist’s Role in Prediabetes Management

Cited by 9 publications

References 23 publications

3. Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes—2023

3. Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes—2023

Community Pharmacy Engagement in Diabetes Prevention: Key Informant Interviews with Pharmacy Executives

3. Prevention or Delay of Type 2 Diabetes and Associated Comorbidities: Standards of Medical Care in Diabetes—2022

Contact Info

Product

Resources

About